![](https://www.lji.org/wp-content/uploads/2020/06/GENERIC-360x240.jpg)
NIH awards Emory $35.6 million grant for research aimed at HIV/AIDS vaccine and cure
![](https://www.lji.org/wp-content/uploads/2020/06/GENERIC-360x240.jpg)
New research center at UC San Diego to focus on microbiome and immunology
![](https://www.lji.org/wp-content/uploads/2020/06/GENERIC-360x240.jpg)
Kirin and Astellas Enter Into a Licensing Agreement on an Immunosuppressive Fully Human Monoclonal Antibody
Kirin Brewery Company, Limited and Astellas Pharma Inc. announced today that they have entered into a license and collaborative research and development agreement.
![](https://www.lji.org/wp-content/uploads/2020/06/GENERIC-360x240.jpg)
Sanofi-aventis and Kyowa Hakko Kirin enter into a Collaboration and Licensing Agreement on an Anti LIGHT fully human monoclonal antibody
Paris, France – May 14, 2009 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Kyowa Hakko Kirin Co., Ltd. (Kyowa
![](https://www.lji.org/wp-content/uploads/2020/06/GENERIC-360x240.jpg)
Do germs trigger type 1 diabetes?
Germs could play a role in the development of type 1 diabetes by triggering the body's immune system to destroy the cells that produce insulin, new research suggests.
![](https://www.lji.org/wp-content/uploads/2020/06/GENERIC-360x240.jpg)
Scientists uncover key pathway in production and maturity of Anti-pathogen B cells
![](https://www.lji.org/wp-content/uploads/2020/06/GENERIC-360x240.jpg)
Key to powerful antibody production found
Discovery led by La Jolla Institute scientists may help with vaccines, autoimmune diseases.
![](https://www.lji.org/wp-content/uploads/2016/05/114368_web.jpg)
LJI scientists discover molecular mechanism for generating specific antibody responses to pathogens
LA JOLLA, CA—Follicular helper T cells (Tfh cells), a rare type of T cells, are indispensible for the maturation of